Mereo Biopharma Group Stock Price on September 10, 2024
| MREO Stock | USD 3.76 0.05 1.31% |
Below is the normalized historical share price chart for Mereo BioPharma Group extending back to April 24, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mereo BioPharma stands at 3.76, as last reported on the 26th of December, with the highest price reaching 3.88 and the lowest price hitting 3.47 during the day.
If you're considering investing in Mereo Stock, it is important to understand the factors that can impact its price. Mereo BioPharma Group has Sharpe Ratio of -0.0237, which conveys that the firm had a -0.0237% return per unit of risk over the last 3 months. Mereo BioPharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mereo BioPharma's insignificant Risk Adjusted Performance, standard deviation of 3.52, and Mean Deviation of 2.48 to check out the risk estimate we provide.
At this time, Mereo BioPharma's Common Stock Total Equity is very stable compared to the past year. As of the 26th of December 2024, Common Stock Shares Outstanding is likely to grow to about 692.4 M, while Total Stockholder Equity is likely to drop about 44.6 M. . At this time, Mereo BioPharma's Price Book Value Ratio is very stable compared to the past year. As of the 26th of December 2024, Price Earnings To Growth Ratio is likely to grow to 2.56, while Price To Sales Ratio is likely to drop 135.14. Mereo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of April 2019 | 200 Day MA 3.7564 | 50 Day MA 4.289 | Beta 0.97 |
Mereo |
Sharpe Ratio = -0.0237
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MREO |
Estimated Market Risk
| 3.55 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mereo BioPharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mereo BioPharma by adding Mereo BioPharma to a well-diversified portfolio.
Price Book 8.1491 | Enterprise Value Ebitda (1.21) | Price Sales 591.1063 | Shares Float 485.1 M | Wall Street Target Price 7.22 |
Related Headline
Hepion Pharmaceuticals Headline on 10th of September 2024
Acquisition by Lbiati Kaouthar of 85000 shares of Hepion Pha... by Lbiati Kaouthar
Filed transaction by Hepion Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Mereo BioPharma Valuation on September 10, 2024
It is possible to determine the worth of Mereo BioPharma on a given historical date. On September 10, 2024 Mereo was worth 4.54 at the beginning of the trading date compared to the closed value of 4.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mereo BioPharma stock. Still, in general, we apply an absolute valuation method to find Mereo BioPharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mereo BioPharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mereo BioPharma's related companies.
| Open | High | Low | Close | Volume | |
| 4.37 | 4.51 | 4.33 | 4.49 | 638,808 | |
09/10/2024 | 4.54 | 4.72 | 4.52 | 4.69 | 516,374 |
| 4.64 | 4.71 | 4.56 | 4.66 | 514,314 |
| Backtest Mereo BioPharma | | | Mereo BioPharma History | | | Mereo BioPharma Valuation | Previous | Next |
Mereo BioPharma Trading Date Momentum on September 10, 2024
| On September 11 2024 Mereo BioPharma Group was traded for 4.66 at the closing time. The top price for the day was 4.71 and the lowest listed price was 4.56 . The trading volume for the day was 514.3 K. The trading history from September 11, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.64% . The trading delta at closing time against the current closing price is 8.53% . |
Mereo BioPharma Group Fundamentals Correlations and Trends
By evaluating Mereo BioPharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mereo BioPharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mereo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mereo BioPharma Stock history
Mereo BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mereo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mereo BioPharma Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mereo BioPharma stock prices may prove useful in developing a viable investing in Mereo BioPharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 659.5 M | 692.4 M | |
| Net Loss | -30.8 M | -32.3 M |
Mereo BioPharma Quarterly Net Working Capital |
|
Mereo BioPharma Stock Technical Analysis
Mereo BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mereo BioPharma Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Mereo BioPharma Group cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mereo BioPharma December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Mereo BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mereo BioPharma shares will generate the highest return on investment. By undertsting and applying Mereo BioPharma stock market strength indicators, traders can identify Mereo BioPharma Group entry and exit signals to maximize returns
Mereo BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mereo BioPharma's price direction in advance. Along with the technical and fundamental analysis of Mereo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mereo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mereo BioPharma Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo BioPharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.25) | Revenue Per Share 0.007 | Return On Assets (0.24) | Return On Equity (0.48) |
The market value of Mereo BioPharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo BioPharma's market value can be influenced by many factors that don't directly affect Mereo BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mereo BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.